Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 9 January 2017
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 9 January 2017. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that the Board of Directors has decided to establish a pharmaceuticals manufacturing subsidiary company in Nairobi, Kenya. The Initial estimated total project cost will be US$ 20.00 million. US$ 8.00 million of it will be financed by equity investment by the company for which Bangladesh Bank has given permission and the balance would be invested from loan. It is expected that the project would be completed by June 2019.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b000040060532
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.